- Report
- May 2024
- 140 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1896EUR$2,000USD£1,584GBP
- Report
- August 2022
Global
From €749EUR$790USD£626GBP
- Report
- June 2022
- 93 Pages
Global
From €1896EUR$2,000USD£1,584GBP
The Tetanus Drug market is a subset of the Infectious Diseases Drugs market. It is composed of drugs used to treat tetanus, a bacterial infection caused by the Clostridium tetani bacteria. Symptoms of tetanus include muscle spasms, difficulty swallowing, and lockjaw. Treatment typically involves antibiotics, antitoxins, and supportive care. Vaccines are also available to prevent the disease.
The Tetanus Drug market is highly competitive, with a number of companies offering products. Some of these companies include GlaxoSmithKline, Pfizer, Merck, Sanofi, and Novartis. Show Less Read more